Global Biolabs Report 2023
Since its inception in May 2021, the Global BioLabs initiative has identified notable trends in global data on BSL4 and BSL3+ laboratories and on biorisk management at both the national and international level. Overall, there are several trends that raise biosafety and biosecurity concerns given the global boom in construction of BSL4 and BSL3+ labs, particularly where biorisk management oversight is weak.
Maximum Biocontainment
Clinical work and scientific studies on pathogens, or disease-causing biological agents, are important for public health, biomedical advances, and disease prevention. Some of these activities, however, pose significant risks.